Full Press Release Details
MARLBOROUGH, Mass. , April 28, 2016 /PRNewswire/ -- Boston Scientific (NYSE: BSX ) today announced key data, including one late-breaking clinical trial, that will be featured at the 37th Annual Scientific Sessions of the Heart Rhythm Society (HRS) in San Francisco on May 4-7 .
Data from the EFFORTLESS study, the first large-scale, multi-national, post-market analysis of safety and efficacy of the subcutaneous implantable defibrillator (S-ICD), will be featured at the late-breaking clinical trial session on Friday, May 6 . Other presentations and abstracts of interest include:
"We are enthusiastic about the breadth of robust data that we will be presenting at this year's congress, especially the data related to the performance of the S-ICD during the late-breaking clinical trial session" said Kenneth Stein , M.D., chief medical officer, Rhythm Management, Boston Scientific. "We are eager to present new evidence supporting our modular approach to leadless pacing and defibrillation, as well as proof that our mapping technology continues to set new standards of performance in the electrophysiology space."
ABSTRACTS OF INTEREST (listed chronologically within product categories)
Subcutaneous Implantable Defibrillator (S-ICD)
Rhythmia Mapping System
Cardiac Resynchronization Therapy Defibrillator (CRT-D) and Implantable Defibrillator (ICD)
WATCHMAN LAAC Device
All presentations are listed in Pacific Time and will take place at Moscone Center. For more information, visit Boston Scientific at booth #1805.
The company will also host an investor event and webcast on May 5 from 2:00 – 3:30 PM PDT to provide a presentation and answer questions from investors about the Boston Scientific rhythm management portfolio. The event will be accessible via live webcast at www.bostonscientific.com/investors . A replay of the webcast will be accessible at www.bostonscientific.com/investors beginning approximately one hour following the completion of the event.
Caution: The leadless pacemaker is a concept device or technology and not available for use or sale.
About Boston Scientific Boston Scientific transforms lives through innovative medical solutions that improve the health of patients around the world. As a global medical technology leader for more than 35 years, we advance science for life by providing a broad range of high performance solutions that address unmet patient needs and reduce the cost of healthcare. For more information, visit www.bostonscientific.com and connect on Twitter and Facebook .
CONTACTS: Laura Aumann Media Relations Boston Scientific Corporation (651) 582-4251 (office) [email protected]
Susie Lisa , CFA Investor Relations Boston Scientific Corporation (508) 683-5565 (office) [email protected]
SOURCE Boston Scientific Corporation